Brought to you by 
Glaukos brings in $29.5mm through its Series E round
01 Mar 2011
Executive Summary
Glaukos Corp. (ophthalmic device for glaucoma) has raised $29.5mm through its Series E venture round. Meritech Capital Partners led the financing ($16mm) and was joined by current shareholders Versant Ventures, Domain Associates, Frazier Healthcare Ventures, InterWest Partners, Montreux Equity Partners, OrbiMed Advisors, and 11 other undisclosed investors.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Glaukos brings in $29.5mm through its Series E round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice